MA41574B2 - Pde9 inhibitors with an imidazo triazinone backbone and an imidazo pyrazinone backbone for the treatment of peripheral diseases - Google Patents

Pde9 inhibitors with an imidazo triazinone backbone and an imidazo pyrazinone backbone for the treatment of peripheral diseases

Info

Publication number
MA41574B2
MA41574B2 MA41574A MA41574A MA41574B2 MA 41574 B2 MA41574 B2 MA 41574B2 MA 41574 A MA41574 A MA 41574A MA 41574 A MA41574 A MA 41574A MA 41574 B2 MA41574 B2 MA 41574B2
Authority
MA
Morocco
Prior art keywords
backbone
imidazo
treatment
triazinone
pde9 inhibitors
Prior art date
Application number
MA41574A
Other languages
French (fr)
Other versions
MA41574A1 (en
Inventor
Niels Svenstrup
Kate Wen
Yazhou Wang
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck As filed Critical H Lundbeck As
Priority claimed from PCT/EP2016/065964 external-priority patent/WO2017005786A1/en
Publication of MA41574A1 publication Critical patent/MA41574A1/en
Publication of MA41574B2 publication Critical patent/MA41574B2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des inhibiteurs de pde9 et leur utilisation pour le traitement de l'hyperplasie bénigne de la prostate et de la drépanocytose.The present invention relates to pde9 inhibitors and their use for the treatment of benign prostatic hyperplasia and sickle cell anemia.

MA41574A 2015-07-07 2016-07-06 Pde9 inhibitors with an imidazo triazinone backbone and an imidazo pyrazinone backbone for the treatment of peripheral diseases MA41574B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201500393 2015-07-07
PCT/EP2016/065964 WO2017005786A1 (en) 2015-07-07 2016-07-06 Pde9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases

Publications (2)

Publication Number Publication Date
MA41574A1 MA41574A1 (en) 2018-07-31
MA41574B2 true MA41574B2 (en) 2021-09-30

Family

ID=63639456

Family Applications (1)

Application Number Title Priority Date Filing Date
MA41574A MA41574B2 (en) 2015-07-07 2016-07-06 Pde9 inhibitors with an imidazo triazinone backbone and an imidazo pyrazinone backbone for the treatment of peripheral diseases

Country Status (1)

Country Link
MA (1) MA41574B2 (en)

Also Published As

Publication number Publication date
MA41574A1 (en) 2018-07-31

Similar Documents

Publication Publication Date Title
TN2017000507A1 (en) Pde9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases
PH12019502810A1 (en) Bicyclic heterocycles as fgfr inhibitors
MX2022004513A (en) Bicyclic heterocycles as fgfr inhibitors.
PH12017501481A1 (en) Bicyclic heterocycles as fgfr inhibitors
MX356107B (en) Histidyl-trna synthetases for treating autoimmune and inflammatory diseases.
PH12017501483A1 (en) Bicyclic heterocycles as fgfr4 inhibitors
MX2022010638A (en) Pde9 inhibitors for treatment of peripheral diseases.
MA40755B1 (en) Compositions comprising bacterial strains
MA40754B1 (en) Compositions comprising bacterial strains
MA38183A1 (en) Pyrrolopyrimidine compounds as kinase inhibitors
MX2020010412A (en) Inhibitors of bruton's tyrosine kinase.
EA201691114A1 (en) BIARRYLIC CONNECTIONS USED IN THE TREATMENT OF HUMAN DISEASES IN ONCOLOGY, NEPHROLOGY AND IMMUNOLOGY
EA201690746A1 (en) TREATMENT WITH THE USE OF BLUTON AND IMMUNOTHERAPY THYROZINKINASE INHIBITORS
EA201500393A1 (en) BLUTON TYROSINKINASE INHIBITORS
EA201101666A1 (en) 3- [4- (7H-PYRROLO [2,3-d] PYRIMIDIN-4-IL) -1H-PYRAZOL-1-IL] OCTAN-OR GEPTANNITRIL AS JAK-INHIBITORS
TW201613919A (en) Inhibitors of Bruton's tyrosine kinase
EA201690502A1 (en) SUBSTITUTED PYRIMIDINE INHIBITORS BMI-1
MA38827A1 (en) Combination of a mek inhibitor and an erk inhibitor for use in the treatment of hyperproliferative diseases
MX2023000191A (en) Methods of making and using pde9 inhibitors.
EA202191301A1 (en) COMPOSITION OF TABLETS 2-FLUORO-N-METHYL-4- [7- (QUINOLIN-6-YLMETHYL) IMIDAZO [1,2-b] [1,2,4] TRIAZIN-2-YL] BENZAMIDE
MA41574B2 (en) Pde9 inhibitors with an imidazo triazinone backbone and an imidazo pyrazinone backbone for the treatment of peripheral diseases
MA44025B1 (en) Pde9 inhibitors for the treatment of peripheral diseases
MA40042B1 (en) Prohemostatic proteins for the treatment of bleeding
UA36915U (en) Eye drops for treating inflammatory diseases of choroids and dry keratoconjunctivitis caused by autoimmune processes
TR201711933A2 (en) HETEROCYCLIC COMPOUNDS THAT ARE SELECTIVE INHIBITING THE TYROZINE KINASE 2 (TYK2) ENZYME